MESA LABORATORIES INC /CO/ reported financial results for three months ended March 31, 2026.
“On May 27, 2026, Mesa Laboratories, Inc. issued a press release relating to its results for the three and twelve months ended March 31, 2026.”
MESA LABORATORIES INC /CO/ — fact timeline
Source-grounded facts extracted from MESA LABORATORIES INC /CO/'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
MESA LABORATORIES INC /CO/ reported financial results for fiscal year ended March 31, 2026.
“On May 27, 2026, Mesa Laboratories, Inc. issued a press release relating to its results for the three and twelve months ended March 31, 2026.”
MESA LABORATORIES INC /CO/ incurred credit facility of $97 million at a base rate or a SOFR rate, plus an applicable spread maturing April 5, 2029.
“On August 12, 2025, Mesa Laboratories, Inc. ("the "Company") drew $97 million under its existing Credit Facility.”
Moss Adams LLP resigned as auditor of MESA LABORATORIES INC /CO/.
“On June 3, 2025, Mesa Laboratories, Inc., (the "Company") was notified that Moss Adams LLP ("Moss Adams"), the Company's independent registered public accounting firm, merged with Baker Tilly US, LLP effective on June 3, 2025. The combined audit practices operate as Baker Tilly US, LLP (“Baker Tilly”). In connection with the notification of the merger, Moss Adams has resigned as the auditors of the Company and the Audit Committee of the Company’s Board of Directors approved the appointment of Baker Tilly, as the successor to Moss Adams, as the Company’s independent registered public accounting firm.”
MESA LABORATORIES INC /CO/ amended Credit Agreement with syndicate of banks led by JPMorgan Chase Bank, N.A., as administrative agent (effective 2024-04-05).
“On April 5, 2024, Mesa Laboratories, Inc. (the “Company” “we” “us” or “our”) amended and restated its senior secured credit agreement (the “Credit Agreement”) with a syndicate of banks led by JPMorgan Chase Bank, N.A., as administrative agent.”
MESA LABORATORIES INC /CO/ reported third fiscal quarter ended December 31, 2023 results: revenue $53,473, net income $2,116, EPS $0.39 per diluted share of common stock.
“● Non-GAAP adjusted operating income excluding unusual items as a percentage of revenues increased sequentially to 22.4% Executive Commentary (amounts in thousands) “Revenues of $53,473 for the quarter decreased 1.5% as compared to the third quarter of fiscal year 2023 (“3Q23”), due primarily to a 9.0% core organic revenues (“core organic”) decrease which was”
Mark Capone was appointed as Director at MESA LABORATORIES INC /CO/.
“Effective January 5, 2024, the Board of Directors (“Board”) of Mesa Laboratories, Inc. (“Mesa ”), upon the recommendation of its Nominating and Governance Committee, voted to expand the size of the Board from six to seven members, and to appoint Mark Capone to fill the newly created seat.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.